Aerie Pharmaceuticals Inc

NASDAQ:AERI  
15.13
+0.01 (+0.07%)
Mergers / Acquisitions

Alcon To Acquire Aerie Pharmaceuticals, Inc., Enhancing Its Ophthalmic Pharmaceutical Portfolio

Published: 08/23/2022 01:27 GMT
Aerie Pharmaceuticals Inc (AERI) - Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing Its Ophthalmic Pharmaceutical Portfolio.
Transaction Values Aerie at Approximately $770 Million in Equity Value and is Expected to Be Accretive to Alcon's Core Diluted EPS in 2024.
Transaction Was Approved by Board of Directors of Each Company.
Purchase Price of $15.25 per Share to Aerie's Last Closing Price, Represents an Equity Value of Approximately $770 Million.